US Patent 11225475 Substituted pyridines as inhibitors of histone deacetylase
Patent 11225475 was granted and assigned to Alkermes (company) on January, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 22 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 2 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 4 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 13 Dec, 2023
Golden AI
Edits made to:
Article (+230 characters)
Article
Patent abstract
Provided herein are compounds and pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful in the treatment of conditions associated with inhibition of HDAC (e.g., HDAC2).
Edits on 29 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
112254750
Date of Patent
January 18, 2022
0Patent Application Number
166369690
Date Filed
August 7, 2018
0Patent Primary Examiner
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
112254750
Date of Patent
January 18, 2022
0Patent Application Number
166369690
Date Filed
August 7, 2018
0Patent Primary Examiner
Edits on 21 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 11225475 Substituted pyridines as inhibitors of histone deacetylase
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11225475
Date of patent
January 18, 2022
Patent application number
16636969
Date Filed
August 7, 2018
Patent primary examiner
Find more entities like US Patent 11225475 Substituted pyridines as inhibitors of histone deacetylase
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.